Neurotech

Innovative Robotic Nerve Cuffs Revolutionize Neurocare

Innovative Robotic Nerve Cuffs Revolutionize Neurocare

Leave a Comment / Neureads-daily, Research papers /

Innovative Robotic Nerve Cuffs Revolutionize Neurocare Researchers from the University of Cambridge have developed groundbreaking tiny, flexible devices capable of wrapping around individual nerve fibers without causing damage. These innovative nerve cuffs, employing a combination of flexible electronics and soft robotics techniques, offer promising applications in diagnosing and treating neurological disorders like epilepsy, chronic pain, […]

Innovative Robotic Nerve Cuffs Revolutionize Neurocare Read More »

NeuroVigil

NeuroVigil’s iBrain: Revolutionizing Brain Monitoring without the Needles

Leave a Comment / Uncategorized /

NeuroVigil’s iBrain: Revolutionizing Brain Monitoring without the Needles NeuroVigil, a leading neurotechnology company, launched its iBrain™ Personal Brain Monitor in four US states, selling 1.4% of its stock for over $85 million. This propelled the company’s valuation to over $6 billion, making it the highest Series B financing in history. The financing, which involved 27

NeuroVigil’s iBrain: Revolutionizing Brain Monitoring without the Needles Read More »

Synchron Advances Toward Large-Scale Brain Implant Trials, Emerging as a Challenger to Neuralink

Synchron Readies for Large-Scale Brain Implant Trials, Posing Challenge to Neuralink

Leave a Comment / Neureads-daily /

Synchron Gears Up for Large-Scale Brain Implant Trials, Challenging Neuralink Synchron Inc., backed by investors including Jeff Bezos and Bill Gates, is poised to challenge Elon Musk’s Neuralink with its innovative brain implant technology. The company, based in New York, is preparing to recruit patients for a pivotal clinical trial aimed at securing commercial approval

Synchron Readies for Large-Scale Brain Implant Trials, Posing Challenge to Neuralink Read More »

Neuronetics' magnetic stimulation cleared as first-line add-on therapy for adolescents with severe depression

FDA Clears NeuroStar for Adolescent Depression – A Brighter Future for Teen Mental Health?

1 Comment / Neureads-daily /

FDA Clears NeuroStar for Adolescent Depression – A Brighter Future for Teen Mental Health? Neuronetics‘ NeuroStar recently received FDA approval as an add-on therapy for adolescents aged 15 to 21 suffering from major depressive disorder (MDD). This groundbreaking approval represents a significant advance in the treatment of young people’s mental health. Depression in adolescents is

FDA Clears NeuroStar for Adolescent Depression – A Brighter Future for Teen Mental Health? Read More »

Neurable Inc. and Healthspan Digital Inc. Announce Partnership to Empower Precision Health and Longevity Clinics with Brain-Computer Interface Technologies

Neurable & Healthspan Partner to Redefine Precision Health and Longevity Clinics

Leave a Comment / Neureads-daily /

Neurable & Healthspan Partner to Redefine Precision Health and Longevity Clinics Neurable Inc., a leader in brain-computer interface (BCI) technology, and Healthspan Digital Inc., a Canadian HealthTech company specializing in precision health and longevity solutions, have announced a strategic partnership. The collaboration aims to commercialize Neurable’s advanced brain health tools and empower precision health and

Neurable & Healthspan Partner to Redefine Precision Health and Longevity Clinics Read More »

SOOMA SECURES €5M FUNDING FOR AT-HOME BRAIN STIMULATION FOR DEPRESSION

This Company Raises €5M for Depression Treatment

Leave a Comment / Neureads-daily, Startups /

In the ever-evolving landscape of mental health treatment, Sooma Medical emerges as a beacon of innovation and hope. With its pioneering approach to depression treatment using Transcranial Direct Current Stimulation (tDCS), Sooma is reshaping the way we perceive and address mental health challenges. Through a combination of cutting-edge technology, clinical expertise, and a relentless commitment to patient care, Sooma is paving the way for a brighter future for individuals battling depression worldwide.

This Company Raises €5M for Depression Treatment Read More »

FDA FINDS PROBLEMS AT ANIMAL LAB RUN BY MUSK’S BRAIN IMPLANT COMPANY

FDA Raises Concerns: Neuralink Faces Quality Control Issues in Animal Experiments

1 Comment / Neureads-daily /

FDA Raises Concerns: Neuralink Faces Quality Control Issues in Animal Experiments Recent reports have surfaced alarming concerns about Neuralink’s quality control practices, prompting FDA scrutiny. Inspections at Neuralink’s California facility revealed troubling lapses in record-keeping and quality controls. These findings raise questions about the reliability of Neuralink’s experimental data and its readiness for human trials,

FDA Raises Concerns: Neuralink Faces Quality Control Issues in Animal Experiments Read More »

Samphire Neuroscience, a cutting-edge medtech startup, just secured an impressive $2.3 million

Say Goodbye to Period Pain: How This Startup Raised $2.3M to Tackle PMS with Neurotech Wearables!

Leave a Comment / Neureads-daily, Resources, Startups /

Say Goodbye to Period pain: How This Startup Raised $2.3M to Tackle PMS with Neurotech Wearable! Exciting news is on the horizon for women’s health! Samphire Neuroscience, a cutting-edge medtech startup, just secured an impressive $2.3 million in pre-seed funding to push forward their groundbreaking neurotechnology wearable, Nettle. This innovative device is set to shake

Say Goodbye to Period Pain: How This Startup Raised $2.3M to Tackle PMS with Neurotech Wearables! Read More »

Subscribe
Subscribe